Argyle Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.15M	Sell	25,884 -1,081	-4%	-$89.6K	1.77%	9
2025 Q1	$2.19M	Buy	26,965 +4,582	+20%	+$372K	1.87%	9
2024 Q4	$2.02M	Buy	+22,383	New	+$2.02M	1.73%	9